Cargando…
Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649283/ http://dx.doi.org/10.1186/2051-1426-3-S2-P377 |
_version_ | 1782401324132859904 |
---|---|
author | Wang, Liang-Chuan S Koblish, Holly Hansbury, Michael Zhang, Yue Yang, Gengjie Burn, Timothy Waeltz, Paul Rupar, Mark Yue, Eddy Douty, Brent Maduskuie, Thomas Falahatpisheh, Nikoo Li, Yun-Long Combs, Andrew P Hollis, Gregory Huber, Reid Scherle, Peggy |
author_facet | Wang, Liang-Chuan S Koblish, Holly Hansbury, Michael Zhang, Yue Yang, Gengjie Burn, Timothy Waeltz, Paul Rupar, Mark Yue, Eddy Douty, Brent Maduskuie, Thomas Falahatpisheh, Nikoo Li, Yun-Long Combs, Andrew P Hollis, Gregory Huber, Reid Scherle, Peggy |
author_sort | Wang, Liang-Chuan S |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4649283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46492832015-11-24 Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents Wang, Liang-Chuan S Koblish, Holly Hansbury, Michael Zhang, Yue Yang, Gengjie Burn, Timothy Waeltz, Paul Rupar, Mark Yue, Eddy Douty, Brent Maduskuie, Thomas Falahatpisheh, Nikoo Li, Yun-Long Combs, Andrew P Hollis, Gregory Huber, Reid Scherle, Peggy J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649283/ http://dx.doi.org/10.1186/2051-1426-3-S2-P377 Text en Copyright © 2015 Wang et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Wang, Liang-Chuan S Koblish, Holly Hansbury, Michael Zhang, Yue Yang, Gengjie Burn, Timothy Waeltz, Paul Rupar, Mark Yue, Eddy Douty, Brent Maduskuie, Thomas Falahatpisheh, Nikoo Li, Yun-Long Combs, Andrew P Hollis, Gregory Huber, Reid Scherle, Peggy Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents |
title | Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents |
title_full | Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents |
title_fullStr | Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents |
title_full_unstemmed | Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents |
title_short | Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents |
title_sort | pharmacological inactivation of pi3kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649283/ http://dx.doi.org/10.1186/2051-1426-3-S2-P377 |
work_keys_str_mv | AT wangliangchuans pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT koblishholly pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT hansburymichael pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT zhangyue pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT yanggengjie pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT burntimothy pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT waeltzpaul pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT ruparmark pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT yueeddy pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT doutybrent pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT maduskuiethomas pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT falahatpishehnikoo pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT liyunlong pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT combsandrewp pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT hollisgregory pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT huberreid pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents AT scherlepeggy pharmacologicalinactivationofpi3kdinthetumormicroenvironmentenhancesefficacyofotherimmunotherapeuticagents |